Onco Bcg Vaccine

Onco Bcg Vaccine Specification

Dosage Form
Injection

Indication
Intravesical immunotherapy for early-stage bladder cancer

Salt Composition
BCG (Bacillus Calmette-Guerin) live attenuated

Enzyme Types
N/A (live attenuated bacteria)

Feature
Sterile, lyophilized, single-dose

Ingredients
BCG strain, stabilizers, saline

Application
For intravesical use only

Ph Level
Neutral

Temperature Needed For Fermentation
35-37C (BCG culturing)

Physical Color/Texture
White to pale yellow powder

Fermentation Smell
Odorless after reconstitution

Storage Instructions
Store at 2C to 8C (Refrigerator)

Shelf Life
36 Months

Reconstitution
With saline before use

Product Form
Lyophilized powder

Usage
Immunotherapy; bladder cancer

Packaging Size
10 ml

Packaging Type
Vial

Bacterial Strain
Bacillus Calmette-Guerin

Route
Intravesical instillation

Onco Bcg Vaccine Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About Onco Bcg Vaccine

Unlock a valuable therapeutic solution with Onco Bcg Vaccine-an advanced, trending choice in bladder cancer immunotherapy. Specially formulated as a sterile, lyophilized powder, this product harnesses the transcendent power of Bacillus Calmette-Guerin (BCG) live attenuated bacteria, offering a rising standard for early-stage bladder cancer treatment. With soaring efficacy, the vaccine is reserved for intravesical instillation, ensuring targeted and meaningful immunotherapy. Reconstitute with saline to achieve optimal results and trust in its neutral pH and reliable stability for impactful administration.

Specific Usage and Key Advantages of Onco Bcg Vaccine

Onco Bcg Vaccine is exclusively administered via intravesical instillation for early-stage bladder cancer. Every 10 ml vial contains lyophilized BCG, ensuring optimal dosage for immunotherapy. Competitive advantages include sterile, single-dose packaging and a shelf life of 36 months, making it reliable for exporters and wholesalers in India. The vaccine maintains stability under refrigeration and remains odorless post-reconstitution, providing peace of mind through superior quality and handling ease for clinicians.

Payment Terms, Certifications, and Supply Capabilities

We offer flexible payment options tailored for institutional and bulk procurement orders. Each batch of Onco Bcg Vaccine is supported by internationally recognized certifications, assuring unwavering commitment to quality standards. Our robust supply chain enables consistent dispatching and secure shipping, with capacity to meet soaring demand across domestic and export markets. With dependable storage protocols and swift order fulfillment, clients experience a seamless process from ordering to delivery every time.

FAQ's of Onco Bcg Vaccine:

Q: How should Onco Bcg Vaccine be administered for best results?

A: Onco Bcg Vaccine is administered exclusively via intravesical instillation, directly into the bladder, following reconstitution with saline to ensure proper dosage and efficacy.

Q: What is the process for reconstituting Onco Bcg Vaccine?

A: Before usage, the lyophilized powder must be dissolved in saline solution, resulting in a ready-to-administer, odorless suspension suitable for intravesical immunotherapy.

Q: When should Onco Bcg Vaccine be used in bladder cancer treatment?

A: This vaccine is indicated primarily for patients with early-stage bladder cancer, providing immunotherapy to help prevent recurrence and progression of the disease.

Q: Where should the vaccine be stored to maintain its quality?

A: Onco Bcg Vaccine should be stored in a refrigerator, at a consistent temperature between 2C to 8C, to maintain sterility and stability for up to 36 months.

Q: What are the key benefits of choosing Onco Bcg Vaccine for immunotherapy?

A: It offers sterile, single-dose vials with a long shelf life, a proven BCG strain for effective immunotherapy, and robust supply assurance for both domestic and export needs.

Tell us about your requirement